Table 5.
Treatment | YPF | PSS |
---|---|---|
µmol m−2 s−1 | Pfr:Ptotal | |
B | 88 | 0.51 |
G | 94 | 0.83 |
GB | 90 | 0.62 |
R | 114 | 0.89 |
RB | 98 | 0.86 |
RG | 106 | 0.88 |
RGB | 102 | 0.86 |
RGB + FR | 104 | 0.76 |
Treatment | YPF | PSS |
---|---|---|
µmol m−2 s−1 | Pfr:Ptotal | |
B | 88 | 0.51 |
G | 94 | 0.83 |
GB | 90 | 0.62 |
R | 114 | 0.89 |
RB | 98 | 0.86 |
RG | 106 | 0.88 |
RGB | 102 | 0.86 |
RGB + FR | 104 | 0.76 |